Sulopenem Disk Development, Quality Control Range, and MIC to Disk Result Correlation for Enterobacterales Isolates
Open Access
- 20 July 2023
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 61 (7) , e0024623
Abstract
Sulopenem disk masses of 2, 5, 10, and 20 μg were evaluated by susceptibility testing isolates by broth microdilution and disk diffusion. A 2-μg disk was chosen, and error-rate bounding analysis in accordance with Clinical and Laboratory Standards Institute (CLSI) guideline M23 was conducted using a proposed sulopenem susceptible/intermediate/resistant (S/I/R) interpretive criterion of ≤0.5/1/≥2 μg/mL.Keywords
This publication has 4 references indexed in Scilit:
- The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017PLOS ONE, 2019
- In Vitro Activity of Sulopenem, an Oral Penem, against Urinary Isolates of Escherichia coliAntimicrobial Agents and Chemotherapy, 2019
- Delafloxacin In Vitro Broth Microdilution and Disk Diffusion Antimicrobial Susceptibility Testing Guidelines: Susceptibility Breakpoint Criteria and Quality Control Ranges for an Expanded-Spectrum Anionic FluoroquinoloneJournal of Clinical Microbiology, 2018
- The Continued Value of Disk Diffusion for Assessing Antimicrobial Susceptibility in Clinical Laboratories: Report from the Clinical and Laboratory Standards Institute Methods Development and Standardization Working GroupJournal of Clinical Microbiology, 2018